Alpha Tau Medical Ltd (DRTS) Financials

DRTS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 134.3 million 90.2 million
March 31, 2026 108.8 million 39.4 million
Dec. 31, 2025 105.7 million 28.6 million
Sept. 30, 2025 104.7 million 27.1 million

DRTS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 ? 6.7 million
March 31, 2026 ? ?
Dec. 31, 2025 -32.8 million ?
Sept. 30, 2025 ? -5.3 million

DRTS Net Income

No data available :(

DRTS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 100.6 million 6.8 million 8.3 million
March 31, 2026 80.2 million 6.4 million 7.9 million
Dec. 31, 2025 73.1 million 6.4 million 7.4 million
Sept. 30, 2025 72.2 million 6.2 million 7.3 million

DRTS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 91.0 million
March 31, 2026 89.7 million
Dec. 31, 2025 85.7 million
Sept. 30, 2025 85.3 million

DRTS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 9.9 million 3.9 million 311000
March 31, 2026 - 11.0 million 2.3 million 241000
Dec. 31, 2025 6.1 million 9.6 million 3.0 million 452000
Sept. 30, 2025 - 8.3 million 2.4 million 490000

DRTS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -

DRTS

Price: $14.43

52 week price:
3.35
15.10

Earnings Per Share: -1.04 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.3 billion

Links: